摘要
目的:分析丙种球蛋白联合阿莫西林克拉维酸钾治疗小儿重症腺病毒肺炎的临床效果。方法:选取2018年11月-2019年11月110例小儿重症腺病毒肺炎患儿,随机分为两组,对照组行阿莫西林克拉维酸钾治疗,试验组行丙种球蛋白联合阿莫西林克拉维酸钾治疗,观察两组治疗效果。结果:试验组治疗有效率为96.36%,显著高于对照组的83.36%,差异有统计学意义(P<0.05);试验组呼吸机使用时间、发热时间、住院时间均短于对照组,差异有统计学意义(P<0.05);试验组并发症发生率为5.45%,低于对照组的18.18%,差异有统计学意义(P<0.05)。结论:丙种球蛋白联合阿莫西林克拉维酸钾治疗小儿重症腺病毒肺炎的效果显著,促进患儿恢复,减少并发症的发生。
Objective:To analyze the clinical efficacy of Gamma Globulin combined with Amoxicillin Clavulanate Potassium in the treatment of children with severe adenovirus pneumonia.Method:A total of 110 children with severe adenovirus pneumonia from November 2018 to November 2019 were selected and randomly divided into two groups.The control group was treated with Amoxicillin Clavulanate Potassium,and the experimental group was treated with Gamma Globulin combined with Amoxicillin Clavulanate Potassium.The effects of the two groups were compared.Result:The effective rate of the experimental group was 96.36%,significantly higher than 83.36%of the control group,the difference was significant(P<0.05);the ventilator use time,fever time and hospitalization time in the experimental group were shorter than those in the control group,the differences were significant(P<0.05);the complication rate of the experimental group was 5.45%,which was lower than 18.18%of the control group,the difference was significant(P<0.05).Conclusion:The effect of Gamma Globulin combined with Amoxicillin Clavulanate Potassium in the treatment of children with severe adenovirus pneumonia is significant,which can promote the recovery of children and reduce the incidence of complications.
作者
邱倩瑛
QIU Qianying(Xiamen Children’s Hospital,Xiamen 361000,China)
出处
《中外医学研究》
2021年第16期148-150,共3页
CHINESE AND FOREIGN MEDICAL RESEARCH
关键词
小儿重症腺病毒肺炎
阿莫西林克拉维酸钾
丙种球蛋白
Severe adenovirus pneumonia in children
Amoxicillin Clavulanate Potassium
Gamma Globulin